SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-056416
Filing Date
2023-10-30
Accepted
2023-10-30 16:47:24
Documents
12
Period of Report
2023-10-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rphm-20231030.htm   iXBRL 8-K 48244
  Complete submission text file 0000950170-23-056416.txt   175661

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rphm-20231030.xsd EX-101.SCH 2483
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rphm-20231030_pre.xml EX-101.PRE 11566
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rphm-20231030_lab.xml EX-101.LAB 18693
6 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20231030_htm.xml XML 4891
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 231360949
SIC: 2834 Pharmaceutical Preparations